Repligen (RGEN) Cost of Revenue (2010 - 2026)

Repligen (RGEN) has reported Cost of Revenue for 17 consecutive years, with $94.1 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Cost of Revenue rose 5.28% year-over-year to $94.1 million; the TTM figure through Jun 2026 stood at $362.4 million (down 2.9% YoY), while the FY2025 annual figure was $352.0 million, down 2.16% from the prior year.
• Cost of Revenue rose to $94.1 million in Q2 2026 per RGEN's latest filing, from $86.0 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $128.7 million in Q4 2024 and bottomed at $76.4 million in Q1 2024.
• Historically, Cost of Revenue has averaged $88.3 million across 5 years, with a median of $86.4 million in 2022.
• Annual changes were most pronounced in 2024 — Cost of Revenue jumped 46.03% — and 2025, when it fell 26.9%.
• Repligen's Cost of Revenue stood at $90.7 million in 2022, then declined by 2.83% to $88.1 million in 2023, then surged by 46.03% to $128.7 million in 2024, then dropped by 26.9% to $94.1 million in 2025, then advanced by 0.01% to $94.1 million in 2026.
• Business Quant data shows RGEN's Cost of Revenue at $94.1 million in Q2 2026, $86.0 million in Q1 2026, and $94.1 million in Q4 2025.